Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 5 Patient-related outcomes following structured relearning of individually daily living tasksa

From: Structured relearning of activities of daily living in dementia: the randomized controlled REDALI-DEM trial on errorless learning

   

Baseline

Week 11

Week 16

Week 26

Sample errorless

Sample trial and error

Errorless,

Baseline trial and error,

Errorless,

Trial and error,

Group ∆,

Errorless,

Trial and error,

Group ∆,

Errorless,

Trial and error,

Group ∆,

(N)

(N)

mean (SD)

mean (SD)

mean (SD)

mean (SD)

mean (95% CI)

mean (SD)

mean (SD)

mean (95% CI)

mean (SD)

mean (SD)

mean (95% CI)

Primary patient-related outcome

 Task performance rating video A (1 = worst, 7 = best)

69

71

3.0 (1.6)

3.5 (1.5)

4.3 (1.7)

4.2 (1.7)

–0.1 (–0.6, 0.5)

4.4 (1.8)

4.1 (1.8)

0.3 (–0.3, 0.9)

3.8 (1.8)

4.0 (1.7)

0.3 (–0.5, 0.8)

 Task performance rating video B (1 = worst, 7 = best)

69

71

3.1 (1.6)

3.9 (1.7)

4.7 (1.6)

4.3 (1.6)

–0.4 (–0.9, 0.1)

4.3 (1.8)

4.4 (1.6)

–0.1 (–0.5, 0.7)

4.1 (2.0)

3.9 (1.9)

–0.2 (–0.9, 0.5)

Secondary patient-related outcomes

 IDDD A initiative (0 = worst, 36 = best)

69

71

18.4 (6.6)

18.2 (5.8)

   

17.7 (7.0)

16.8 (7.2)

–0.9 (–3.3, 1.5)

16.2 (7.5)

15.7 (7.4)

–0.4 (–3.1, 2.0)

 IDDD B performance (44 = worst, 0 = best)

69

71

21.3 (6.0)

21.4 (7.2)

   

21.0 (8.6)

20.9 (9.0)

0.0 (–3.0, 2.9)

22.3 (10.2)

23.6 (10.1)

1.4 (–2.1, 4.8)

 Treatment satisfaction (5 = worst, 1 = best)

69

71

  

1.5 (0.6)

1.5 (0.5)

0.0 (–0.2, 0.2)

   

1.5 (0.9)

1.4 (0.7)

–0.1 (–0.4, 0.2)

Control measures

 MMSE (0 = worst, 30 = best)

69

71

19.8 (3.3)

19.7 (3.3)

   

19.0 (4.8)

19.6 (4.2)

0.6 (–0.9, 2.1)

18.2 (5.2)

18.9 (5.1)

0.7 (–1.1, 2.4)

 Reisberg Clinical Dementia Rating (1 = worst, 7 = best)

69

71

4.3 (0.6)

4.3 (0.7)

   

4.4 (0.6)

4.4 (0.7)

0.1 (–0.2, 0.3)

4.4 (0.6)

4.4 (1.0)

0.0 (–0.3, 0.3)

 NPIQ (36 = worst, 0 = best)

69

71

7.2 (4.0)

7.5 (5.2)

   

7.9 (5.2)

8.1 (5.2)

–0.1 (–1.7, 1.8)

8.0 (5.4)

8.6 (6.5)

0.6 (–1.5, 2.7)

  1. SD standard deviation, IDDD Interview for Deterioration in Daily Living Activities, MMSE Mini Mental State Examination, NPIQ Neuropsychiatric Inventory Questionnaire
  2. aIntention-to-treat analysis of 140 participants with follow-up data at week 16 and multiple imputations when data were missing in single measurement instruments